Skip to main content

Table 1 Summary of available studies reporting on gemcitabine in the treatment of chondrosarcomas (all histotypes)

From: Response of conventional chondrosarcoma to gemcitabine alone: a case report

 

Type of study

Regimen

Patients (n)

Best response (RECIST)

Merimsky et al., 2000 [25]

Prospective

Gemcitabine alone

3

2 SD, 1 PD

Fox et al., 2012 [8]

Prospective

Gemcitabine/docetaxel

25

2 PR, 14 SD, 9 PD

Italiano et al., 2013 [7]

Retrospective

Gemcitabine-based combinations

n/a

3 PR

  1. Legend. RECIST: response evaluation criteria in solid tumour; SD: stable disease; PD: progressive disease; PR: partial response; n/a: not available.